ProvideGx secured long-term supply of two medications vital to caring for patients with COVID-19, Premier announced Thursday (May 28). Premier’s drug shortage program contracted Hikma Pharmaceuticals to supply amiodarone and sterile water. Amiodarone is used to manage heart complications common in seriously ill COVID-19 patients. It’s not on the FDA’s drug shortage list, but Premier’s purchasing data shows that just 55 percent of orders are being filled due to increase demand. Sterile water is on the American Society of Health-System...